High-Dose First-Line Treatment Regimen for Recurrent Rifampicin-Susceptible Tuberculosis.
Tom DecrooBouke C de JongAlberto PiubelloMahamadou Bassirou SouleymaneLutgarde LynenArmand Van DeunPublished in: American journal of respiratory and critical care medicine (2020)